Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIV(mac251) at Challenge Exposure

We used the simian immunodeficiency virus mac251 (SIV(mac251)) macaque model to study the effect of the dose of mucosal exposure on vaccine efficacy. We immunized macaques with a DNA prime followed by SIV gp120 protein immunization with ALVAC-SIV and gp120 in alum, and we challenged them with SIV(ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vaccari, Monica, Keele, Brandon F., Bosinger, Steven E., Doster, Melvin N., Ma, Zhong-Min, Pollara, Justin, Hryniewicz, Anna, Ferrari, Guido, Guan, Yongjun, Forthal, Donald N., Venzon, David, Fenizia, Claudio, Morgan, Tia, Montefiori, David, Lifson, Jeffrey D., Miller, Chris J., Silvestri, Guido, Rosati, Margherita, Felber, Barbara K., Pavlakis, George N., Tartaglia, James, Franchini, Genoveffa
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3592147/
https://ncbi.nlm.nih.gov/pubmed/23325681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02863-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados